NCT03245151 2023-08-30Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System TumorsEisai Inc.Phase 1/2 Completed64 enrolled 29 charts